ParissaTabrizianMD
General Surgery • New York, NYTransplantation
Associate, Surgery, Icahn School of Medicine at Mount Sinai
Are you Dr. Tabrizian?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 41 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St
New York, NY 10029Phone+1 212-659-8084Fax+1 646-537-9238
Summary
- Dr. Parissa Tabrizian, MD is a general surgeon in New York, New York. She is currently licensed to practice medicine in New York. She is affiliated with The Mount Sinai Hospital and is an Associate at Icahn School of Medicine at Mount Sinai.
Education & Training
Icahn School of Medicine at Mount SinaiResidency, Surgery, 2005 - 2006
University of Vienna Faculty of MedicineClass of 2002
Certifications & Licensure
NY State Medical License 2011 - 2026- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial Start of enrollment: 2017 Jan 31
Publications & Presentations
PubMed
- Hepatic Resection for Hepatocellular Carcinoma.Parissa Tabrizian, Adriana Pero, Myron Schwartz
Clinics in Liver Disease. 2025-02-01 - 8 citationsImpact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis.Mohammad Saeid Rezaee-Zavareh, Yee Hui Yeo, Tielong Wang, Zhiyong Guo, Parissa Tabrizian
Journal of Hepatology. 2025-01-01 - Sociodemographic disparities in downstaging to liver transplant for hepatocellular carcinoma.Kali Zhou, Lauren Nguyen, Parissa Tabrizian, Neil Mehta
Liver Transplantation. 2024-11-08
Press Mentions
Immunotherapy Shows Promise in Downstaging Liver Tumors Prior to TransplantNovember 19th, 2024- "Downstaging" Liver Cancer Before Transplant Improves OutcomesJuly 25th, 2022
- Shrinking Liver Cancer Tumors Before Transplant Yields Excellent Outcomes, Mount Sinai Researchers ReportJuly 20th, 2022
Professional Memberships
- Member
